1. < Publications

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022

By sjmartinez • January 26, 2023

Lewis NM, Murray N, Adams K, Surie D, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Shapiro NI, Gibbs KW, Files DC, Hager DN, Ali H, Prekker ME, Frosch AE, Exline MC, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Lauring AS, Khan A, Hough CL, Busse LW, Bender W, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Chappell JD, Halasa N, Grijalva CG, Rice TW, Stubblefield WB, Baughman A, Lindsell CJ, Hart KW, Rhoads JP, McMorrow ML, Tenforde MW, Self WH, Patel MM; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022. Open Forum Infect Dis. 2022 Dec 31;10(1):ofac698. doi: 10.1093/ofid/ofac698. PMID: 36695662; PMCID: PMC9868348.

Tags: absolute vaccine effectiveness, booster vaccine series, covid-19, primary vaccine series, Publications, Pulmonary, Critical Care & Sleep Medicine, relative vaccine effectiveness

Related Posts

Not Always the Herpes You Think: A Case Report of Genital Zoster

Reed DV. Not Always the Herpes You Think: A Case Report of Genital Zoster. Cureus. 2026 May 18;18(5):e109149. doi: 10.7759/cureus.109149. PMID: 42326154; PMCID: PMC13278140.

Alopecia Areata Is Associated with Increased Risk of Infertility in a Retrospective Cohort Study Using TriNetX

Podolsky AS, Goh C, Lipner SR. Alopecia Areata Is Associated with Increased Risk of Infertility in a Retrospective Cohort Study Using TriNetX. Skin Appendage Disord.[...]

Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial

Olszewski AJ, Avigdor A, Babu S, Levi I, Eradat H, Abadi U, Holmes H, McKinney MS, Woszczyk D, Giannopoulos K, Jurczak W, Jing J, Li[...]